These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

267 related items for PubMed ID: 11359428

  • 1. The release of histamine is associated with the inactivation of mast cell chymase during immediate allergic wheal reaction in the skin.
    Saarinen JV, Harvima RJ, Naukkarinen A, Horsmanheimo M, Harvima IT.
    Clin Exp Allergy; 2001 Apr; 31(4):593-601. PubMed ID: 11359428
    [Abstract] [Full Text] [Related]

  • 2. Interleukin-4-positive mast cells are highly associated with the extent of immediate allergic wheal reaction in the skin.
    Saarinen JV, Harvima RJ, Naukkarinen A, Horsmanheimo M, Harvima IT.
    Allergy; 2001 Jan; 56(1):58-64. PubMed ID: 11167353
    [Abstract] [Full Text] [Related]

  • 3. Release of histamine and leukotriene C4 in immediate allergic wheal reaction as measured with the microdialysis technique.
    Saarinen JV, Harvima RJ, Naukkarinen A, Horsmanheimo M, Harvima IT.
    Arch Dermatol Res; 2000 Jul; 292(7):333-40. PubMed ID: 10966057
    [Abstract] [Full Text] [Related]

  • 4. Mast cells in developing subepidermal bullous diseases: emphasis on tryptase, chymase and protease inhibitors.
    Kaminska R, Naukkarinen A, Glinski W, Horsmanheimo M, Harvima IT.
    Acta Derm Venereol; 1999 Sep; 79(5):351-5. PubMed ID: 10494709
    [Abstract] [Full Text] [Related]

  • 5. Release of soluble tryptase but only minor amounts of chymase activity from cutaneous mast cells.
    Kivinen PK, Kaminska R, Naukkarinen A, Harvima RJ, Horsmanheimo M, Harvima IT.
    Exp Dermatol; 2001 Aug; 10(4):246-55. PubMed ID: 11493313
    [Abstract] [Full Text] [Related]

  • 6. Decreased chymase activity is associated with increased levels of protease inhibitors in mast cells of psoriatic lesions.
    Harvima IT, Haapanen L, Ackermann L, Naukkarinen A, Harvima RJ, Horsmanheimo M.
    Acta Derm Venereol; 1999 Mar; 79(2):98-104. PubMed ID: 10228625
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Mast cell tryptase and chymase in chronic leg ulcers: chymase is potentially destructive to epithelium and is controlled by proteinase inhibitors.
    Huttunen M, Harvima IT.
    Br J Dermatol; 2005 Jun; 152(6):1149-60. PubMed ID: 15948975
    [Abstract] [Full Text] [Related]

  • 9. Mast cell chymase potentiates histamine-induced wheal formation in the skin of ragweed-allergic dogs.
    Rubinstein I, Nadel JA, Graf PD, Caughey GH.
    J Clin Invest; 1990 Aug; 86(2):555-9. PubMed ID: 2384602
    [Abstract] [Full Text] [Related]

  • 10. The increase in tryptase- and chymase-positive mast cells is associated with partial inactivation of chymase and increase in protease inhibitors in basal cell carcinoma.
    Diaconu NC, Kaminska R, Naukkarinen A, Harvima RJ, Harvima IT.
    J Eur Acad Dermatol Venereol; 2007 Aug; 21(7):908-15. PubMed ID: 17658999
    [Abstract] [Full Text] [Related]

  • 11. The activation of synovial mast cells: modulation of histamine release by tryptase and chymase and their inhibitors.
    He S, Gaça MD, Walls AF.
    Eur J Pharmacol; 2001 Feb 02; 412(3):223-9. PubMed ID: 11166285
    [Abstract] [Full Text] [Related]

  • 12. Mast cell tryptase and chymase in developing and mature psoriatic lesions.
    Harvima IT, Naukkarinen A, Paukkonen K, Harvima RJ, Aalto ML, Schwartz LB, Horsmanheimo M.
    Arch Dermatol Res; 1993 Feb 02; 285(4):184-92. PubMed ID: 8342961
    [Abstract] [Full Text] [Related]

  • 13. Mast cell tryptase and chymase in the progress of cutaneous vasculitis.
    Lipitsä T, Naukkarinen A, Harvima IT.
    Arch Dermatol Res; 2015 Dec 02; 307(10):917-24. PubMed ID: 26498154
    [Abstract] [Full Text] [Related]

  • 14. Biological functions of serine proteases in mast cells in allergic inflammation.
    Katunuma N, Kido H.
    J Cell Biochem; 1988 Dec 02; 38(4):291-301. PubMed ID: 2467915
    [Abstract] [Full Text] [Related]

  • 15. A sensitive colorimetric assay for the release of tryptase from human lung mast cells in vitro.
    Lavens SE, Proud D, Warner JA.
    J Immunol Methods; 1993 Nov 05; 166(1):93-102. PubMed ID: 7693824
    [Abstract] [Full Text] [Related]

  • 16. Mast cell tryptase in dermal neurogenic inflammation.
    Schmelz M, Zeck S, Raithel M, Rukwied R.
    Clin Exp Allergy; 1999 May 05; 29(5):695-702. PubMed ID: 10231325
    [Abstract] [Full Text] [Related]

  • 17. Human mast cell tryptase: a stimulus of microvascular leakage and mast cell activation.
    He S, Walls AF.
    Eur J Pharmacol; 1997 Jun 05; 328(1):89-97. PubMed ID: 9203574
    [Abstract] [Full Text] [Related]

  • 18. The inhibition of mast cell activation by neutrophil lactoferrin: uptake by mast cells and interaction with tryptase, chymase and cathepsin G.
    He S, McEuen AR, Blewett SA, Li P, Buckley MG, Leufkens P, Walls AF.
    Biochem Pharmacol; 2003 Mar 15; 65(6):1007-15. PubMed ID: 12623133
    [Abstract] [Full Text] [Related]

  • 19. Mechanisms of nonimmunological histamine and tryptase release from human cutaneous mast cells.
    Veien M, Szlam F, Holden JT, Yamaguchi K, Denson DD, Levy JH.
    Anesthesiology; 2000 Apr 15; 92(4):1074-81. PubMed ID: 10754628
    [Abstract] [Full Text] [Related]

  • 20. Immunoglobulin E-bearing cells and mast cells in skin biopsies of horses with urticaria.
    Rüfenacht S, Marti E, von Tscharner C, Doherr MG, Forster U, Welle M, Roosje PJ.
    Vet Dermatol; 2005 Apr 15; 16(2):94-101. PubMed ID: 15842539
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.